Next Article in Journal
Health Benefits of Urban Allotment Gardening: Improved Physical and Psychological Well-Being and Social Integration
Previous Article in Journal
Knowledge and Attitudes of Dentists with Respect to the Risks of Blood-Borne Pathogens—A Cross-Sectional Study in Poland
Article Menu

Export Article

Open AccessReview
Int. J. Environ. Res. Public Health 2017, 14(1), 68; doi:10.3390/ijerph14010068

New Immunotherapy Strategies in Breast Cancer

1
Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, China
2
Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha 410078, China
*
Author to whom correspondence should be addressed.
Academic Editor: William Chi-shing Cho
Received: 9 October 2016 / Revised: 5 January 2017 / Accepted: 9 January 2017 / Published: 12 January 2017
(This article belongs to the Section Public Health)
View Full-Text   |   Download PDF [1110 KB, uploaded 12 January 2017]   |  

Abstract

Breast cancer is the most commonly diagnosed cancer among women. Therapeutic treatments for breast cancer generally include surgery, chemotherapy, radiotherapy, endocrinotherapy and molecular targeted therapy. With the development of molecular biology, immunology and pharmacogenomics, immunotherapy becomes a promising new field in breast cancer therapies. In this review, we discussed recent progress in breast cancer immunotherapy, including cancer vaccines, bispecific antibodies, and immune checkpoint inhibitors. Several additional immunotherapy modalities in early stages of development are also highlighted. It is believed that these new immunotherapeutic strategies will ultimately change the current status of breast cancer therapies. View Full-Text
Keywords: breast cancer; immunotherapy; cancer vaccines; bispecific antibodies; immune checkpoint inhibitors; stimulatory molecule agonists breast cancer; immunotherapy; cancer vaccines; bispecific antibodies; immune checkpoint inhibitors; stimulatory molecule agonists
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Yu, L.-Y.; Tang, J.; Zhang, C.-M.; Zeng, W.-J.; Yan, H.; Li, M.-P.; Chen, X.-P. New Immunotherapy Strategies in Breast Cancer. Int. J. Environ. Res. Public Health 2017, 14, 68.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Int. J. Environ. Res. Public Health EISSN 1660-4601 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top